Work

Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: Data from >600 patients in the control arm of the STAMPEDE trial (NCT00268476).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.5012

Authors: Noel W Clarke, Nicholas David James, Malcolm David Mason, Daniel M. Aebersold, David Paul Dearnaley, Johann Sebastian De Bono, Chris Parker, Mahesh Parmar, Alastair WS Ritchie, J. Martin Russell, Melissa Ruth Spears, George N. Thalmann, Matthew Robert Sydes, STAMPEDE Investigators

Institutions: The Christie Hospital, The Christie NHS Foundation Trust, University of Birmingham, Cardiff University, University of Bern, Institute of Cancer Research, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust, MRC Clinical Trials Unit at UCL, University of Glasgow, University Hospital of Bern

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W564441098

Cites:

Cited by: 4

Related to: 10